Department of Laboratory Medicine

Medicine & Life Sciences

1. SARS Virus 100%
2. Japan 83%
3. Blood Platelets 82%
4. Coronavirus 71%
5. Mycobacterium avium Complex 68%
6. Platelet Glycoprotein GPIb-IX Complex 58%
7. Pulmonary Hypertension 58%
8. Lung 54%
9. Lung Diseases 54%
10. von Willebrand Factor 52%
11. Infections 47%
12. Transcatheter Aortic Valve Replacement 46%
13. Balloon Angioplasty 44%
14. Vaccination 44%
15. Severe Acute Respiratory Syndrome 43%
16. Genes 36%
17. Serum 35%
18. Antibodies 35%
19. Genotype 32%
20. Platelet Aggregation 32%
21. Megakaryocytes 32%
22. Platelet Membrane Glycoproteins 31%
23. Aspirin 30%
24. Mutation 29%
25. Therapeutics 28%
26. Acute Promyelocytic Leukemia 28%
27. Echocardiography 28%
28. Hematopoietic Stem Cell Transplantation 26%
29. In Vitro Techniques 26%
30. Thrombotic Thrombocytopenic Purpura 26%
31. Neoplasms 25%
32. Aortic Valve Insufficiency 24%
33. Health Personnel 24%
34. Cross-Sectional Studies 24%
35. Tokyo 24%
36. riociguat 24%
37. Cellular Immunity 24%
38. Right Ventricular Function 24%
39. Standing Position 23%
40. Population 23%
41. Hemodynamics 23%
42. University Hospitals 23%
43. Polymerase Chain Reaction 22%
44. Anticoagulants 22%
45. Observational Studies 22%
46. Three-Dimensional Echocardiography 22%
47. Chronic Obstructive Pulmonary Disease 21%
48. Cerebrovascular Disorders 21%
49. Thrombosis 21%
50. human MIRN346 microRNA 21%
51. Incidence 20%
52. Homologous Transplantation 20%
53. Cell Line 20%
54. Supine Position 20%
55. Obstructive Sleep Apnea 20%
56. Hematology 20%
57. Odds Ratio 20%
58. Stroke Volume 19%
59. Elderly 19%
60. Vaccines 19%
61. Bone Marrow Transplantation 19%
62. Tretinoin 18%
63. Coronary Artery Disease 18%
64. Integrins 18%
65. Confidence Intervals 18%
66. Liposomes 18%
67. Antithrombins 18%
68. Tomography 18%
69. Cohort Studies 17%
70. Idiopathic Thrombocytopenic Purpura 17%
71. Myeloid Cells 17%
72. Pneumocystis Pneumonia 17%
73. Mycobacterium abscessus 17%
74. Epitopes 17%
75. Alleles 17%
76. Pulmonary Arterial Hypertension 16%
77. Genetic Polymorphisms 16%
78. Acquired Thrombotic thrombocytopenic purpura 16%
79. Primary Prevention 16%
80. Mycobacterium 16%
81. Transesophageal Echocardiography 16%
82. Neutralizing Antibodies 16%
83. Humoral Immunity 15%
84. Autoantibodies 15%
85. Acute Lung Injury 15%
86. polyglucosan 15%
87. Bone Marrow 15%
88. Thrombopoietin 15%
89. Liver 15%
90. Migraine Disorders 15%
91. Fibrinogen 14%
92. Immunoglobulin G 14%
93. Pneumonia 14%
94. Single Nucleotide Polymorphism 14%
95. Messenger RNA 14%
96. Bacteremia 14%
97. Interleukin-6 13%
98. Mitral Valve 13%
99. Wilms Tumor 13%